Russell Howard

Russell Howard

Head of Commercial Strategy for Genomics, Genome

Russell Howard is an experienced CEO who has led several successful life-sciences and biotechnology companies, both private and public. He has published over 140 peer-reviewed scientific publications and serves on the board of several companies and foundations in the U.S. and overseas. Today Russell works in Sydney with NeuClone, dedicated to bringing affordable biosimilar monoclonal antibodies to the world, and Genome. One where whole genome sequencing is being commercialised to provide new products and services based on personalised medicine.

Categorías de conocimiento

To know more

What if AI spirals out of control? Shahar Avin highlights the existential risks

What if AI spirals out of control? Shahar Avin highlights the existential risks

Can AI spiral out of control and endanger humanity? Shahar Avin explores the most extreme scenarios at the Future Trends Forum

Read more
Sovereign AI: the new race for technological autonomy

Sovereign AI: the new race for technological autonomy

Jordan Sun warns about the new race for technological sovereignty: without their own AI capabilities, countries and companies will find themselves subordinated. The Future Trends Forum examines the risks and strategies to avoid dependence on the big tech companies

Read more
Jeremy Kahn – Beyond the Hype: The Real Trends in Artificial Intelligence

Jeremy Kahn – Beyond the Hype: The Real Trends in Artificial Intelligence

Fortune Magazine’s AI editor cuts through the media noise and points toward a future for artificial intelligence that is more useful, safer, and more human-centered

Read more